Unknown

Dataset Information

0

FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?

ABSTRACT:

SUBMITTER: Lamarca A 

PROVIDER: S-EPMC7597489 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?

Lamarca Angela A   Foster Lucy L   Valle Juan W JW   Satyadas Thomas T   Siriwardena Ajith A  

ESMO open 20201001 5

Similar Datasets

Unknown FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.
| S-EPMC7498966 | biostudies-literature
Unknown Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.
| S-EPMC8185101 | biostudies-literature
Unknown Meta-analysis of FOLFIRINOX-based neoadjuvant therapy for locally advanced pancreatic cancer.
| S-EPMC7837836 | biostudies-literature
Unknown Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX.
| S-EPMC7309587 | biostudies-literature
Unknown Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study.
| S-EPMC8508515 | biostudies-literature
Unknown Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer
| S-EPMC9812488 | biostudies-literature
Unknown FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.
| S-EPMC8287268 | biostudies-literature
Unknown FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
| S-EPMC5527756 | biostudies-literature
Unknown Duodenal stenosis caused by locally advanced upper tract urothelial carcinoma: a case report.
| S-EPMC10614511 | biostudies-literature
Unknown A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report.
| S-EPMC6803604 | biostudies-literature